MIP-I Antibodies

Target Information

MIP-1, also known as Macrophage Inflammatory Protein-1, is a chemokine encoded by the CCL3 gene. This protein is a member of the CC chemokine family and plays a critical role in the immune response by recruiting and activating various types of leukocytes, including macrophages, T cells, and dendritic cells, to sites of infection or injury. MIP-1 is involved in the inflammatory response, promoting the release of other cytokines and chemokines that amplify the immune reaction. It binds to specific receptors on the surface of target cells, such as CCR1 and CCR5, to exert its effects. Elevated levels of MIP-1 have been associated with various inflammatory and autoimmune conditions, including rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. Additionally, MIP-1 is implicated in the pathogenesis of certain cancers and HIV infection, where it can influence tumor progression and viral replication. Understanding the regulation and function of MIP-1 is crucial for developing targeted therapies aimed at modulating immune responses and treating diseases characterized by excessive inflammation or immune dysregulation. Research into MIP-1 also provides insights into the broader mechanisms of chemokine-mediated cell signaling and its potential therapeutic applications.